Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeAmbuAmbu Announces: Ready to Launch its New Display Technology for Single-Use Endoscopy

Ambu Announces: Ready to Launch its New Display Technology for Single-Use Endoscopy

Ambu announced today that the Ambu® aView™ 2 Advance has now obtained CE mark and is listed at Food and Drug Administration which enables release for sale in Europe and North America by mid-May 2020. The aView 2 Advance is a portable full-HD display unit to be used together with our single-use endoscopes across multiple clinical specialties. Ambu, is a global manufacturer of medical devices, including single-use endoscopes.

“We have pioneered single-use endoscopy for more than ten years, and we now bring our portfolio to a new level of sophistication,” said Juan Jose Gonzalez, CEO of Ambu. “Image quality is critical for healthcare providers and patient diagnosis, and we can now offer a display unit that was not possible with a single-use endoscope just a few years ago. I believe we are raising the bar on innovative technology for hospitals and clinics.”

Jens Kemp, Ambu USA’s Vice President of Marketing said, the aView 2 Advance will fit the needs of clinicians throughout the hospital.

“Its mobile platform not only works well within the ICU, but specialists from other areas can use it to perform everything from cystoscopies to flexible laryngoscopies to bronchoscopies,” Kemp said. “It will increase workflow, efficiency and enable clinicians to address patients quickly.”

A reusable display for single-use devices

The aView 2 Advance is the display unit that clinicians connect a single-use scope into in order to transmit a live image from inside the human body. The scope is single-use and is discarded when the procedure is done – for hygienic, practical and economic reasons – while the display unit is reused as it has not been in contact with the patient.

“The aView 2 Advance seamlessly connects to the aScope family of sterile, single-use flexible endoscopes,” Kemp said. “A live image is displayed within seconds of powering on the monitor providing a high-quality image, with image capture and recording capability, in an easy to use, transportable monitor solution. After the procedure, health care providers can simply clean the monitor using commercially available disinfectant wipes widely used in healthcare.”

Technology for future product development

The aView 2 Advance covers Ambu’s existing endoscopes, which means that it can be used with a bronchoscope (for airway procedures), a rhinolaryngoscope (for ENT procedures) or a cystoscope (for urology procedures). The unit offers full-HD resolution, advanced image processing and an anti-reflective touchscreen. In addition, aView 2 Advance enables users to transfer recorded data to the hospital’s electronic health records (EHR).

The display unit is part of Ambu’s expansion across all major areas of endoscopy, and this technology platform will form the basis for the development of Ambu’s future single-use endoscope devices.

Built on a decade of experience

Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScope™ in 2009. Ten years later, in 2019, over 600,000 Ambu single-use endoscopes were used in more than 3,500 hospitals making Ambu the world’s largest supplier of single-use endoscopes.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy